Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive anaplastic lymphoma kinase (ALK) tyrosine kinase activation by fusion to ATIC, an enzyme involved in purine nucleotide biosynthesis

Blood

Volumn 95, Issue 6, 2000, Pages 2144-2149

  Ma, Zhigui ^b   Cools, Jan ^b   Marynen, Peter ^b   Cui, Xiaoli ^b   Siebert, Reiner ^b   Gesk, Stefan ^b   Schlegelberger, Brigitte ^b   Peeters, Benjamin ^b   De Wolf Peeters, Christiane ^b   Wlodarska, Iwona ^b   Morris, Stephan W ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; ENZYME; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; ENZYME ACTIVATION; ENZYME INDUCTION; LARGE CELL LYMPHOMA; MOUSE; NONHUMAN; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0034653984     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.6.2144     Document Type: Article

References (32)

1. Benharroch D, Meguerian-Bedoyan Z, Lamant L, et al. ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood. 1998;91:2076.
2. Falini B, Pileri S, Zinzani PL, et al. ALK+ lymphoma: clinico-pathological findings and outcome. Blood. 1999;93:2697.
3. Sarris AH, Luthra R, Cabanillas F, Morris SW, Pugh WC. Genomic DNA amplification and the detection of t(2;5)(p23;q35) in lymphoid neoplasms. Leuk Lymphoma. 1998;29:507.
4. Lamant L, Meggetto F, al Saati T, et al. High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining. Blood. 1996;87:284.
5. Morris SW, Kirstein MN, Valentine MB, et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science. 1994;263:1281.
6. Ladanyi M. The NPM/ALK gene fusion in the pathogenesis of anaplastic large cell lymphoma. Cancer Surv. 1997;30:59.
7. Iwahara T, Fujimoto J, Wen D, et al. Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system. Oncogene. 1997;14:439.
8. Morris SW, Naeve C, Mathew P, et al. ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK). Oncogene. 1997;14:2175.
9. Pulford K, Lamant L, Morris SW, et al. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood. 1997;89:1394.
10. Bischof D, Pulford K, Mason DY, Morris SW. Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis. Mol Cell Biol. 1997;17:2312.
11. Wlodarska I, De Wolf-Peeters C, Falini B, et al. The cryptic inv(2)(p23q35) defines a new molecular genetic subtype of ALK-positive ALCL anaplastic large-cell lymphoma. Blood. 1998;92:2688
12. Luthra R, Pugh WC, Waasdorp M, et al. Mapping of genomic t(2;5)(p23;q35) break points in patients with anaplastic large-cell lymphoma by sequencing long-range PCR products. Hematopathol Mol Hematol. 1998;11:173.
13. Rayl EA, Moroson BA, Beardsley GP. The human pur H gene product, 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase. Cloning, sequencing, expression, purification, kinetic analysis, and domain mapping. J Biol Chem. 1996;271:2225.
14. Sugita T, Aya H, Ueno M, Ishizuka T, Kawashima K. Characterization of molecularly cloned human 5-aminoimidazole-4-carboxamide ribonucleotide transformylase. J Biochem. 1997;122:309.
15. Beardsley GP, Rayl EA, Gunn K, et al. Structure and functional relationships in human pur H. Adv Exp Med Biol. 1998;431:221.
16. Stryer L. Biosynthesis of nucleotides. In: Biochemistry. Vol 4. New York, NY: WH Freeman; 1995:739.
17. Bai RY, Dieter P, Peschel C, Morris SW, Duyster J. Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity. Mol Cell Biol. 1998;18:6951.
18. Fujimoto J, Shiota M, Iwahara T, et al. Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5). Proc Natl Acad Sci U S A. 1996;93:4181.
19. Kuefer MU, Look AT, Pulford K, et al. Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice. Blood. 1997;90:2901.
20. Lamant L, Dastugue N, Pulford K, Delsol G, Mariame B. A new fusion gene, TPM3-ALK, in anaplastic large-cell lymphoma created by a (1;2) (q25;p23) translocation. Blood. 1999;93:3088.
21. Sainati L, Montaldi A, Stella M, Putti MC, Zanesco L, Basso G. A novel variant translocation t(2;13) (p23;q34) in Ki-1 large cell anaplastic lymphoma. Br J Haematol. 1990;75:621.
22. Rosenwald A, Ott G, Pulford K, et al. 1(1;2)(q21; p23) and t(2;3)(p23;q21): two novel variant translocations of the t(2;5)(p23;q35) in anaplastic large-cell lymphoma. Blood. 1999;94:362.
23. Butti MG, Bongarzone I, Ferraresi G, Mondellini P, Borrello MG, Pierotti MA. A sequence analysis of the genomic regions involved in the rearrangements between TPM3 and NTRK1 genes producing TRK oncogenes in papillary thyroid carcinomas. Genomics. 1995;28:15.
24. Gascoyne RD, Aoun P, Wu D, et al. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large-cell lymphoma. Blood. 1999;93:3913.
25. Rodrigues GA, Park M. Oncogenic activation of tyrosine kinases. Curr Opin Genet Dev. 1994; 4:15.
26. Xiao S, Nalabolu SR, Aster JC, et al. FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome. Nat Genet. 1998;18:84.
27. Knezevich SR, McFadden DE, Tao W, Lim JF, Sorensen PH. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet. 1998;18: 184.
28. Zalkin H. The amidotransferases. Adv Enzymol Relat Areas Mol Biol. 1993;66:203.
29. Beardsley GP, Moroson BA, Taylor EC, Moran RG. A new folate antimetabolite, 5, 10-dideaza-5,6,7,8-tetrahydrofolate is a potent inhibitor of de novo purine synthesis. J Biol Chem. 1989;264: 328.
30. Kelley JL, McLean EW, Cohn NK, et al. Synthesis and biological activity of an acyclic analogue of 5,6,7,8-tetrahydrofolic acid, N-[4-[3-(2,4-diamino-1,6-dihydro-6-oxo-5-pyrimidinyl) propyl] amino]-benzoyl]-L-glutamic acid. J Med Chem. 1990;33: 561.
31. Hernandez L, Pinyol M, Hernandez S, et al. TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALKtranslocations. Blood. 1999;94:3265.
32. Greco A, Mariani C, Miranda C, et al. The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain. Mol Cell Biol. 1995;15:6118.